Potential Role of Microbiome in Tuberculosis
NCT04985994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2024-10-10
Summary
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a deadly infectious disease and major global public health problem. Recent evidence from animal studies suggests that the microbiome plays a role in TB pathogenesis and immune response. However, until now, no similar study has been performed in humans and thus any influence of the microbiota on TB or vice versa remains unknown.
Conditions
Sponsors & Collaborators
-
University of Reading
collaborator OTHER -
TB Control Program Khyber Pakhtunkhwa
collaborator UNKNOWN -
Khyber Medical University Peshawar
lead OTHER
Principal Investigators
-
Muhammad Shahzad · Khyber Medical University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-22
- Primary Completion
- 2024-03-31
- Completion
- 2024-08-31
Countries
- Pakistan
Study Locations
More Related Trials
-
Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
NCT02225158 ·Status: TERMINATED
-
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
NCT05571735 ·Status: RECRUITING
-
Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis
NCT00926601 ·Status: UNKNOWN
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Latency in Pulmonary Tuberculosis
NCT01154959 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)
NCT03559582 ·Status: COMPLETED
-
Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung
NCT05027958 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
NCT06764576 ·Status: RECRUITING
-
DRug Use & Infections in ViEtnam: TuBerculosis Control
NCT05655702 ·Status: RECRUITING ·Phase: NA
-
Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
NCT06709157 ·Status: NOT_YET_RECRUITING
-
Immunological Biomarkers in Tuberculosis Management
NCT04271397 ·Status: RECRUITING ·Phase: NA
-
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
NCT05621343 ·Status: RECRUITING
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection
NCT03312647 ·Status: UNKNOWN
-
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
NCT05148949 ·Status: UNKNOWN ·Phase: PHASE4
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study
NCT06019052 ·Status: NOT_YET_RECRUITING
-
Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda
NCT01492595 ·Status: COMPLETED
-
Tuberculosis in a Multiethnic Inner City Population
NCT00005379 ·Status: COMPLETED
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
NCT02901288 ·Status: UNKNOWN ·Phase: PHASE4
-
Doxycycline in Human Pulmonary Tuberculosis
NCT02774993 ·Status: COMPLETED ·Phase: PHASE2
-
Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis
NCT06409572 ·Status: NOT_YET_RECRUITING
-
Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein
NCT05746611 ·Status: COMPLETED ·Phase: PHASE4
-
Tuberculosis in China
NCT01071603 ·Status: COMPLETED